BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167 [PMID: 31333308 DOI: 10.3748/wjg.v25.i25.3151]
URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3151.htm
Number Citing Articles
1
Firoz A. Dain Md Opo, Mohammed M. Rahman, Foysal Ahammad, Istiak Ahmed, Mohiuddin Ahmed Bhuiyan, Abdullah M. Asiri. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP proteinScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83626-x
2
Qiuming Su, Lu Li, Xiaokai Li, Wang Li, Xibing Zhang, Yun Dong, Lei Han, Duo Wang, Jianghua Ran. CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinomaWorld Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02829-2
3
Yuan Kong, Xiaoning Zhu, Xue Zhang, Zetian Li, Yue Yin, Jing Wang, Hong Jia. Traditional Chinese medicine combined with radiofrequency ablation improves primary liver cancer outcomes: A systematic review with meta-analysisHeliyon 2023; 9(8): e18591 doi: 10.1016/j.heliyon.2023.e18591
4
Yaochong Tan, Xueting Dong, Donglin Zhuang, Buzi Cao, Hua Jiang, Qingnan He, Mingyi Zhao. Emerging roles and therapeutic potentials of ferroptosis: from the perspective of 11 human body organ systemsMolecular and Cellular Biochemistry 2023; 478(12): 2695 doi: 10.1007/s11010-023-04694-3
5
Maya S. Krishnan, Anand Rajan KD, Jangho Park, Vinodhini Arjunan, Fernando Jose Garcia Marques, Abel Bermudez, Olivia A. Girvan, Nam S. Hoang, Jun Yin, Mindie H. Nguyen, Nishita Kothary, Sharon Pitteri, Dean W. Felsher, Renumathy Dhanasekaran. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive BiomarkersHepatology 2021; 73(6): 2342 doi: 10.1002/hep.31614
6
Tianbing Wang, Bang Chen, Tao Meng, Zhiqiang Liu, Wenyong Wu. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinomaBioengineered 2021; 12(1): 1555 doi: 10.1080/21655979.2021.1918538
7
Ji-An You, Yuhan Gong, Yongzhe Wu, Libo Jin, Qingjia Chi, Da Sun. WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma PatientsFrontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.730920
8
Chun Chen, Yanqiu Gu, Rong Wang, Xinyi Chai, Shuya Jiang, Shaozhan Wang, Zhenyu Zhu, Xiaofei Chen, Yongfang Yuan. Comparative two-dimensional GPC3 overexpressing SK-Hep1 cell membrane chromatography /C18/ time-of-flight mass spectrometry for screening selective GPC3 inhibitor components from Scutellariae RadixJournal of Chromatography B 2021; 1163: 122492 doi: 10.1016/j.jchromb.2020.122492
9
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar. Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitorsMeditsinskiy sovet = Medical Council 2021; (20): 84 doi: 10.21518/2079-701X-2021-20-84-93
10
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma TreatmentVaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
11
Hao Xu, Chen Xiong, Yuan Chen, Chi Zhang, Dousheng Bai. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinomaBioengineered 2021; 12(1): 2664 doi: 10.1080/21655979.2021.1938470
12
Jiaheng Xie, Liang Chen, Qingmei Sun, Haobo Li, Wei Wei, Dan Wu, Yiming Hu, Zhechen Zhu, Jingping Shi, Ming Wang. An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysisAging 2022; 14(7): 3276 doi: 10.18632/aging.204012
13
Wuyu Chen, Minghao Ruan, Minghao Zou, Fuchen Liu, Hui Liu. Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular CarcinomaCancers 2023; 15(16): 4187 doi: 10.3390/cancers15164187
14
Kimia Karimi, Sarah Mojtabavi, Pooya M. Tehrany, Melina Maghsodlou Nejad, Aryan Rezaee, Shahab Mohtashamian, Erfan Hamedi, Farnaz Yousefi, Farshid Salmani, Mohammad Arad Zandieh, Noushin Nabavi, Navid Rabiee, Yavuz Nuri Ertas, Shokooh Salimimoghadam, Mohsen Rashidi, Parham Rahmanian, Kiavash Hushmandi, Wei Yu. Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic applicationInternational Journal of Biological Macromolecules 2023; 242: 124935 doi: 10.1016/j.ijbiomac.2023.124935
15
Ghulam Mustafa, Shumaila Younas, Hafiza Salaha Mahrosh, Mohammed Fahad Albeshr, Eijaz Ahmed Bhat. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9Molecules 2023; 28(8): 3583 doi: 10.3390/molecules28083583
16
Baohui Zhang, Bufu Tang, Jiarui Lv, Jianyao Gao, Ling Qin. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progressionClinical Immunology 2022; 241: 109073 doi: 10.1016/j.clim.2022.109073
17
Xinchen Tian, Tinghao Yan, Fen Liu, Qingbin Liu, Jing Zhao, Huabao Xiong, Shulong Jiang. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insightsFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991052
18
Xueyin Zhou, Jiasheng Cao, Win Topatana, Tianao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanic, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Shen, Mingyu Chen. Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysisImmunotherapy 2023; 15(5): 353 doi: 10.2217/imt-2022-0168
19
Muhammed Mehdi Üremiş, Nuray Üremiş, Yusuf Türköz. Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak/Stat3, ERK/MAPK, PI3K/Akt/mTOR signaling pathwaysSteroids 2023; 198: 109261 doi: 10.1016/j.steroids.2023.109261
20
Lin Sun, Luwen Mu, Jing Zhou, Wenjie Tang, Linqi Zhang, Sidong Xie, Jingbiao Chen, Jin Wang. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinomaCancer Immunology, Immunotherapy 2022; 71(1): 25 doi: 10.1007/s00262-021-02957-w
21
Ola M. S. Khedr, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil, Basma E. Abdel-Maksoud. Lactobacillus acidophilus ATCC 4356 Exopolysaccharides Suppresses Mediators of Inflammation through the Inhibition of TLR2/STAT-3/P38-MAPK Pathway in DEN-Induced Hepatocarcinogenesis in RatsNutrition and Cancer 2022; 74(3): 1037 doi: 10.1080/01635581.2021.1934490
22
Mihai Ceausu, Bogdan Socea, Dragos Serban, Cătălin   Smarandache, Dragoş Predescu, Nicolae Bacalbaşa, Iulian Slavu, Adrian  Tulin, Lucian Alecu, Zenaida Ceauşu. Heterogeneity of antigenic constellation in human hepatocellular carcinomaExperimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9701
23
Jing Liu, Tongyu Liu, Chuanhao Zhang, Jiabei He, Dong Zhou, Zhe Wang, Ruoyu Wang. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.992343
24
Chaohui Liu, Jiansheng Pan, Hongyu Liu, Rongkai Lin, Yijie Chen, Chenghua Zhang. Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β‐catenin signaling pathwayDrug Development Research 2022; 83(4): 952 doi: 10.1002/ddr.21920
25
Xu-Sheng Zhang, Hong-Cai Zhou, Peng Wei, Long Chen, Wei-Hu Ma, Lin Ding, Shi-Cai Liang, Ben-Dong Chen. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responsesWorld Journal of Gastrointestinal Oncology 2023; 15(12): 2138-2149 doi: 10.4251/wjgo.v15.i12.2138
26
Yalei Zhao, Chen Xue, Zhongyang Xie, Xiaoxi Ouyang, Lanjuan Li. Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinomaCell Proliferation 2020; 53(10) doi: 10.1111/cpr.12908
27
Liang Sun, Zhengyi Wu, Cairong Dong, Shian Yu, He Huang, Zhendong Chen, Zhipeng Wu, Xiangbao Yin. Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinomaBMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01558-z
28
Muhammed Mehdi Üremiş, Nuray Üremiş, Emir Tosun, Merve Durhan, Yılmaz Çiğremiş, Ahmet Baysar, Yusuf Türköz. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling PathwaysCurrent Cancer Drug Targets 2022; 22(11): 931 doi: 10.2174/1568009622666220623141158
29
Janis M. Lapsley, Vincent Wavreille, Sabrina Barry, Josephine A. Dornbusch, Carolyn Chen, Haley Leeper, Judith Bertran, Diane Scavelli, Julius M. Liptak, Chris Wood, Shelly Shamir, Claire Rosenbaum, Vincenzo Montinaro, Brandan Wustefeld‐Janssens, Allyson Sterman, Colin Chik, Ameet Singh, Josh Collins, Laura E. Selmic. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control studyVeterinary and Comparative Oncology 2022; 20(3): 697 doi: 10.1111/vco.12824
30
Yakun Wang, Lei Yang, Xichen Dong, Xin Yang, Xinxue Zhang, Zhe Liu, Xin Zhao, Tao Wen, Hui Yu. Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8216541
31
Jing Li, Minling Lv, Qi Huang, Rui Hu, Xin Zhong, Xinfeng Sun, Wenxing Feng, Zhiyi Han, MengQing Ma, Wei Zhang, Xiaozhou Zhou. FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42560-w
32
Pu Wu, Jinyuan Shi, Wei Sun, Hao Zhang. The prognostic value of plasma complement factor B (CFB) in thyroid carcinomaBioengineered 2021; 12(2): 12854 doi: 10.1080/21655979.2021.2005745
33
Kun Zhao, Jie Gao, Jihua Shi, Chengcheng Shi, Chun Pang, Jie Li, Wenzhi Guo, Shuijun Zhang. FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivoOncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13608
34
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A. Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li. A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTORMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01719-9
35
X Liu, H Ren, H Guo, W Wang, N Zhao. Interleukin-35 has a tumor-promoting role in hepatocellular carcinomaClinical and Experimental Immunology 2021; 203(2): 219 doi: 10.1111/cei.13535
36
Mengqi Xin. Research and Treatment Progress of Capmatinib in Hepatocellular CarcinomaHighlights in Science, Engineering and Technology 2022; 8: 576 doi: 10.54097/hset.v8i.1217
37
Di Ma, Juan Wang, Lu Liu, Meiqi Chen, Zhiyong Wang. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical studyBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07447-3
38
Jia-Ren Wang, Rui-Ning Li, Chao-Yi Huang, Chang Hong, Qi-Mei Li, Lin Zeng, Jing-Zhe He, Cheng-Yi Hu, Hao Cui, Li Liu, Lu-Shan Xiao. Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancerLiver Research 2022; 6(3): 175 doi: 10.1016/j.livres.2022.05.004
39
Wenxiong Xu, Yanlin Huang, Yongyu Mei, Yeqiong Zhang, Qiumin Luo, Shu Zhu, Liang Peng, Zhiliang Gao, Ying Liu, Jianguo Li. High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular CarcinomaCurrent Oncology 2022; 29(11): 8650 doi: 10.3390/curroncol29110682
40
Hongzhi Zhao, Liang Zhao, Lin Wu, Sheng Hu, Yangmei Huang, Wei Zhao. Hydrogen sulfide suppresses H2O2-induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathwayMedical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02091-w
41
Yuting Gao, Yi Gong, Yiwei Liu, Yu Xue, Kangning Zheng, Yinglin Guo, Liyuan Hao, Qing Peng, Xinli Shi. Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdownActa Histochemica 2023; 125(1): 151987 doi: 10.1016/j.acthis.2022.151987
42
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
43
Olayinka Fisayo Onifade, Oluseyi Adeboye Akinloye, Oluwatosin A. Dosumu, Abdul Lateef Aderemi Shotuyo. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar ratsFood and Chemical Toxicology 2023; 182: 114096 doi: 10.1016/j.fct.2023.114096
44
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, David S Shin, Wayne Monsky, Chuansheng Zheng, Xiaoming Yang. Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermiaJournal for ImmunoTherapy of Cancer 2022; 10(11): e005619 doi: 10.1136/jitc-2022-005619
45
Wei Wang, Fan Pan, Xinrong Lin, Jiakai Yuan, Chunyu Tao, Rui Wang. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance AnalysisFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.907331
46
Rizwan Qureshi, Bin Zou, Tanvir Alam, Jia Wu, Victor Lee, Hong Yan. Computational Methods for the Analysis and Prediction of EGFR-mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future ProspectsIEEE/ACM Transactions on Computational Biology and Bioinformatics 2022; : 1 doi: 10.1109/TCBB.2022.3141697
47
Wenge Dong, Yangyang Xie, Hai Huang. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular CarcinomaFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.884777
48
Yi Huang, Zhou Yu, Min Zheng, Xiaohong Yang, Honglan Huang, Lijin Zhao. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCCMolecular Medicine Reports 2022; 25(4) doi: 10.3892/mmr.2022.12640
49
Jinlong Liang, Jingyi Wang, Jinshui Zeng, Zhibo Bai, Zhiyuan Zheng, Yue Zheng, Fengqi Jiang, Di Wu, Fu Wang. The Landscape of Early Growth Response Family Members 1-4 in Hepatocellular Carcinoma: Their Biological Roles and Diagnostic UtilityDisease Markers 2022; 2022: 1 doi: 10.1155/2022/3144742
50
Liyang Jia, Yanan Gao, Yaowu He, John D. Hooper, Pengyuan Yang. HBV induced hepatocellular carcinoma and related potential immunotherapyPharmacological Research 2020; 159: 104992 doi: 10.1016/j.phrs.2020.104992
51
Haichuan Wang, Yu Zhang, Li Yan, Qiang Lv, Jie Lu, Bei Yun. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinomaInternational Journal of Immunopathology and Pharmacology 2022; 36: 039463202211329 doi: 10.1177/03946320221132986
52
Hao Liang, Mingxing Xu, Zhiyong Xiong, Kunpeng Hu, Jiarui Yang, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng, Bo Liu. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinomaAging 2021; 13(4): 6115 doi: 10.18632/aging.202606
53
Romelia Pop, Dragoș Hodor, Cornel Cătoi, Teodora Mocan, Lucian Mocan, Alexandru-Flaviu Tăbăran. Unveiling the Role of Concanavalin A in a Rodent Model of Chemical-Induced Hepatocellular Carcinoma: A Promising Guide in Understanding Liver Cancer DevelopmentTargets 2024; 2(1): 52 doi: 10.3390/targets2010003
54
Kai Tan, Kunlei Wang, Anbang Zhao, Zhicheng Liu, Wenjing Song, Qian Cheng, Xinyin Li, Zhinan Chen, Yufeng Yuan, Zhiyong Yang. Meiotic nuclear divisions 1 promotes proliferation and metastasis in hepatocellular carcinoma and is a potential diagnostic and therapeutic target geneMedical Oncology 2022; 40(1) doi: 10.1007/s12032-022-01875-w
55
Liwei Sun, Xuelong Xu, Fanguang Meng, Qian Liu, Hankang Wang, Xiaodong Li, Guijie Li, Feng Chen. Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A reviewFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.980214
56
Xinyue Tu, Jie Zhang, Minjun Li, Fei Lu, Ting Wang, Wenfeng Gong, Bangde Xiang. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial ChemoembolizationJournal of Hepatocellular Carcinoma 2023; : 1881 doi: 10.2147/JHC.S422565
57
Mehrdad Hashemi, Pouria Daneii, Mahya Asadalizadeh, Kiana Tabari, Arash Matinahmadi, Seyed Shahabadin Bidoki, Yasamin Sadat Mousavi Motlagh, Ali Moghadas Jafari, Amin Ghorbani, Amir Dehghanpour, Noushin Nabavi, Shing Cheng Tan, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari, Mohammad Ali Sheikhbeig Goharrizi. Epigenetic regulation of hepatocellular carcinoma progression: microRNAs as therapeutic, diagnostic and prognostic factorsThe International Journal of Biochemistry & Cell Biology 2024; : 106566 doi: 10.1016/j.biocel.2024.106566
58
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
59
Xi Wang, Xuchen Zhang. Hepatocellular adenoma: Where are we now?World Journal of Gastroenterology 2022; 28(14): 1384-1393 doi: 10.3748/wjg.v28.i14.1384
60
Xin Li, Jiahua Xu, Xiaoqiang Gu, Ling Chen, Qing Wu, Hongwei Li, Haoran Bai, Jinzu Yang, Jianxin Qian. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular CarcinomaFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.740790
61
Xiaobin Fei, Songbai Liu, Peng Liu, Xing Wang, Changhao Zhu, Junyi Hou, Junzhe Cai, Yaozhen Pan. Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approachFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1043161
62
Dan Chen, Xiaoting Li, Hui Li, Kai Wang, Xianghua Tian, Jimei Wang. Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5313149
63
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cellsBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
64
Nesil Yalman. LMCD1 antisense RNA 1 is a newly identified long noncoding RNAAnti-Cancer Drugs 2022; 33(1): 1 doi: 10.1097/CAD.0000000000001124
65
Ling Zhang, Tao Wang, Jieqiong Song, Feng Guo. Effect of RhD and RhE sample phenotypic blood transfusion on the prognosis of hepatocellular carcinomaMedicine 2023; 102(49): e36369 doi: 10.1097/MD.0000000000036369
66
Kun He, Mengyi Xie, Weifeng Hong, Yonghe Li, Yaolin Yin, Xiaojin Gao, Yi He, Yu Chen, Chuan You, Jingdong Li. CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinomaThe International Journal of Biochemistry & Cell Biology 2024; 166: 106481 doi: 10.1016/j.biocel.2023.106481
67
Raheleh Roudi, Alberto D'Angelo, Marianna Sirico, Navid Sobhani. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospectsInternational Immunopharmacology 2021; 101: 108322 doi: 10.1016/j.intimp.2021.108322
68
Qiuming Su, Wang Li, Xibing Zhang, Ruichao Wu, Kepu Zheng, Tao Zhou, Yun Dong, Yutao He, Duo Wang, Jianghua Ran. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular CarcinomaCurrent Pharmaceutical Biotechnology 2023; 24(8): 1035 doi: 10.2174/1389201023666220628113452
69
Nuray Üremiş, Muhammed Mehdi Üremiş, Yılmaz Çiğremiş, Emir Tosun, Ahmet Baysar, Yusuf Türköz. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK / STAT3 , MAPK / ERK , and AKT / mTOR signaling pathways in HepG2 cell line Journal of Food Biochemistry 2022; 46(10) doi: 10.1111/jfbc.14333
70
Zhou Lu, Ronghua Liu, Yining Wang, Mengxia Jiao, Zhongchen Li, Zhiqiang Wang, Cheng Huang, Guoming Shi, Aiwu Ke, Luman Wang, Ying Fu, Jie Xia, Haoyu Wen, Jian Zhou, Xiaoying Wang, Dan Ye, Jia Fan, Yiwei Chu, Jiabin Cai. Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinomaHepatology 2023; 77(3): 745 doi: 10.1002/hep.32442
71
Yagmur Azbazdar, Mustafa Karabicici, Esra Erdal, Gunes Ozhan. Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.631623
72
Luyun Yuan, Jinkai Feng, Yuqing Zhang, Chongde Lu, Liu Xu, Chao Liang, Zonghan Liu, Feifei Mao, Yanjun Xiang, Weijun Wang, Kang Wang, Shuqun Cheng. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort studyEuropean Journal of Surgical Oncology 2023; 49(7): 1226 doi: 10.1016/j.ejso.2023.01.020
73
Li Peng, Qi Yan, Zhaolin Chen, Ying Hu, Yuansong Sun, Yu Miao, Yincui Wu, Yan Yao, Liangsong Tao, Fei Chen, He Li, Tao Xu. Research progress on the role of cholesterol in hepatocellular carcinomaEuropean Journal of Pharmacology 2023; 938: 175410 doi: 10.1016/j.ejphar.2022.175410